Author

Nicola Long

Oregon Health & Science UniversityORCID 0000-0002-9010-8167Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alexandria Miller· 1 shared Andy J. KaempfiD· 1 shared Christopher A. EideiD· 1 shared Curtis Lachowiez· 1 shared Daniel BottomlyiD· 1 shared Jean C. Y. WangiD· 1 shared Jeffrey W TyneriD· 1 shared John Edgar DickiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexandria Miller

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard Therapies

Stephen E. Kurtz, Christopher A. Eide, Andy J. Kaempf, Nicola Long, Alexandria Miller, Daniel Bottomly, Shannon K. McWeeney, Curtis Lachowiez, Sudharshan Anand, Stanley Ng, Jean C. Y. Wang, John Edgar Dick, Jeffrey W Tyner

This paper develops a rapid qPCR-based gene expression profiler to predict AML patient response to standard therapies using cell state and BCL2 family gene expression signatures.

bioRxiv · Oct 8, 2025 · PreprintCancer Biology